U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06935084) titled 'ASTHMAXcel Voice Study' on April 11.
Brief Summary: The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
OTHER: ASTHMAXcel Voice platform
ASTHMAXcel Voice is a mobile health application with a multi-level approach to a...